Ephion Health develops digital biomarkers to ensure accurate disease monitoring and therapy assessment, through wearables and AI. We provide a simple, objective and sensitive tool to measure the health of patients based on their functional capacity. The superior sensitivity of our digital biomarkers introduce significant savings in clinical trials, thanks to the reduction of the cohort size and the duration of trials.